Table 2 Clinical characteristics and outcome according to RV dysfunction
RV dysfunction | P value | ||
|---|---|---|---|
Yes (n = 120) | No (n = 128) | ||
Temperature (°) | 37.9 ± 0.3 | 38 ± 0.3 | 0.085 |
PH | 7.31 ± 0.11 | 7.35 ± 0.1 | 0.003* |
Heart rate (bpm) | 103 ± 6 | 102 ± 5 | 0.3 |
Respiratory rate (cycles/min) | 20 ± 3 | 20 ± 2 | 0.858 |
Sodium (meq/L) | 135 ± 5 | 137 ± 4 | < 0.001* |
Potassium (meq/L) | 4.1 ± 0.8 | 3.9 ± 0.6 | 0.02* |
Creatinine (mg/dl) | 1.8 (0.7–5.5) | 1.1 (0.6–5.4) | 0.004* |
Acute renal failure | 61 (50.8) | 48 (37.5) | 0.035* |
Hematocrit (%) | 33 ± 5 | 34 ± 4 | 0.07 |
WBC count | 20.7 ± 4.8 | 19 ± 3.4 | 0.002* |
Glasgow Coma Scale | 15 (3–15) | 15 (3–15) | 0.542 |
FiO2 | |||
> 50% | 55 (45.8) | 43 (33.6) | 0.049* |
< 50% | 65 (54.2) | 85 (66.4) | |
APACHE 2 score | 13 (1–41) | 7 (1–34) | < 0.001* |
Fluid received 6 h before echo (ml) | 1000 (500–3500) | 2000 (500–3000) | < 0.001* |
Receipt of vasopressors during echo | 51 (42.5) | 37 (28.9) | 0.025* |
Norepinephrine equivalent dose (ug/kg/min) | 1.1 (0.2–2.1) | 0.7 (0.2–2) | 0.104 |
Ventilated during echo | 18 (15) | 15 (11.7) | 0.447 |
PaO2/FiO2 ratio | 319 ± 41 | 328 ± 34 | 0.051 |
30-d mortality | 39 (32.5) | 21 (16.4) | 0.003* |
Ventilator-free days (days) | 30 (0–30) | 30 (0–30) | 0.089 |